SL

Shreenaba Lagdhirsinh Jhala

Active Director Designated Partner DIN 07820502
DIN 07820502 First appointment May 2017 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Shreenaba Lagdhirsinh Jhala

Data last updated:

Shreenaba Lagdhirsinh Jhala is a Designated Partner at Amasthenic Healthcare Llp (since 2017). The company operates in Healthcare.

DIN 07820502
Primary Designation Designated Partner
Industry Healthcare
First Appointment 15 May 2017
Oldest Company Age 9 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner15 May 20172017Active

Board colleagues of Shreenaba Lagdhirsinh Jhala

NameDINCompanyDesignation
Poonamben Pradipkumar Shah07753511Amasthenic Healthcare LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Amasthenic Healthcare Llp
Premium access

Shareholding and investment profile for Shreenaba Lagdhirsinh Jhala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shreenaba Lagdhirsinh Jhala

Shreenaba Lagdhirsinh Jhala currently holds 1 directorship: Amasthenic Healthcare Llp (Designated Partner, since 15 May 2017).

Shreenaba Lagdhirsinh Jhala was first appointed on 15 May 2017 as Designated Partner at Amasthenic Healthcare Llp.

The current boards of Shreenaba Lagdhirsinh Jhala's companies include Poonamben Pradipkumar Shah (Amasthenic Healthcare Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available